共 121 条
[11]
Civitelli R(2004)Relationship between pretreatment bone resorption and vertebral fracture incidence in postmenopausal osteoporotic women treated with risedronate J Bone Miner Res 19 323-329
[12]
Gonnelli S(2006)Pretreatment levels of bone turnover and the antifracture efficacy of alendronate: the Fracture Intervention Trial J Bone Miner Res 21 292-299
[13]
Zachei F(2005)Early changes in biochemical markers of bone formation predict BMD response to teriparatide in postmenopausal women with osteoporosis J Bone Miner Res 20 962-970
[14]
Gonnelli S(2006)Fracture risk reduction during treatment with teriparatide is independent of pretreatment bone turnover Bone 39 237-243
[15]
Cepollaro C(2004)The effects of strontium ranelate on the risk of vertebral fracture in women with postmenopausal osteoporosis New Engl J Med 350 459-468
[16]
Pondrelli C(2005)Strontium ranelate reduces the risk of nonvertebral fractures in postmenopausal women with osteoporosis: Treatment of Peripheral Osteoporosis (TROPOS) study J Clin Endocrinol Metab 90 2816-2822
[17]
Gonnelli S(2001)Mechanisms of action and therapeutic potential of strontium in bone Calcif Tissue Int 69 121-129
[18]
Cepollaro C(2005)Strontium ranelate: a novel mode of action of optimizing bone formation and resorption Osteoporos Int 16 S7-S10
[19]
Pondrelli C(2006)Vertebral fracture risk reduction with strontium ranelate in women with postmenopausal osteoporosis is independent of baseline risk factors J Bone Miner Res 21 536-542
[20]
Iwamoto J(2008)Strontium ranelate reduces the risk of vertebral fractures in patients with osteopenia J Bone Miner Res 23 433-438